Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 May;1(3):257–260. doi: 10.1128/cdli.1.3.257-260.1994

Cytokines and cytokine measurements in a clinical laboratory.

T L Whiteside 1
PMCID: PMC368245  PMID: 7496959

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 1990 Aug;4(11):2860–2867. [PubMed] [Google Scholar]
  2. Arend W. P. IL-1 antagonism in inflammatory arthritis. Lancet. 1993 Jan 16;341(8838):155–156. doi: 10.1016/0140-6736(93)90014-8. [DOI] [PubMed] [Google Scholar]
  3. Bagasra O., Seshamma T., Pomerantz R. J. Polymerase chain reaction in situ: intracellular amplification and detection of HIV-1 proviral DNA and other specific genes. J Immunol Methods. 1993 Jan 14;158(1):131–145. doi: 10.1016/0022-1759(93)90265-9. [DOI] [PubMed] [Google Scholar]
  4. Balkwill F. R., Burke F. The cytokine network. Immunol Today. 1989 Sep;10(9):299–304. doi: 10.1016/0167-5699(89)90085-6. [DOI] [PubMed] [Google Scholar]
  5. Bargetzi M. J., Lantz M., Smith C. G., Torti F. M., Olsson I., Eisenberg S. P., Starnes H. F., Jr Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res. 1993 Sep 1;53(17):4010–4013. [PubMed] [Google Scholar]
  6. Borden E. C., Sondel P. M. Lymphokines and cytokines as cancer treatment. Immunotherapy realized. Cancer. 1990 Feb 1;65(3 Suppl):800–814. doi: 10.1002/1097-0142(19900201)65:3+<800::aid-cncr2820651328>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  7. Cannon J. G., van der Meer J. W., Kwiatkowski D., Endres S., Lonnemann G., Burke J. F., Dinarello C. A. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res. 1988 Winter;7(4):457–467. [PubMed] [Google Scholar]
  8. Devergne O., Peuchmaur M., Humbert M., Navratil E., Leger-Ravet M. B., Crevon M. C., Petit M. A., Galanaud P., Emilie D. In vivo expression of IL-1 beta and IL-6 genes during viral infections in human. Eur Cytokine Netw. 1991 May-Jun;2(3):183–194. [PubMed] [Google Scholar]
  9. Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N Engl J Med. 1993 Jan 14;328(2):106–113. doi: 10.1056/NEJM199301143280207. [DOI] [PubMed] [Google Scholar]
  10. Duncan L. M., Meegan L. S., Unanue E. R. IL-1 gene expression in lymphoid tissues. J Immunol. 1991 Jan 15;146(2):565–571. [PubMed] [Google Scholar]
  11. Friberg D., Bryant J., Shannon W., Whiteside T. L. In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation. Clin Diagn Lab Immunol. 1994 May;1(3):261–268. doi: 10.1128/cdli.1.3.261-268.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hopkins S. J., Humphreys M. Bioassay of interleukin-1 in serum and plasma following removal of inhibitory activity with polyethylene glycol. J Immunol Methods. 1990 Oct 4;133(1):127–131. doi: 10.1016/0022-1759(90)90326-q. [DOI] [PubMed] [Google Scholar]
  13. James K. Interactions between cytokines and alpha 2-macroglobulin. Immunol Today. 1990 May;11(5):163–166. doi: 10.1016/0167-5699(90)90067-j. [DOI] [PubMed] [Google Scholar]
  14. Kimchi A. Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem. 1992 Sep;50(1):1–9. doi: 10.1002/jcb.240500102. [DOI] [PubMed] [Google Scholar]
  15. Legoux P., Minty C., Delpech B., Minty A. J., Shire D. Simultaneous quantitation of cytokine mRNAs in interleukin-1 beta stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control. Eur Cytokine Netw. 1992 Nov-Dec;3(6):553–563. [PubMed] [Google Scholar]
  16. Lowenthal J. W., MacDonald H. R. Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med. 1986 Oct 1;164(4):1060–1074. doi: 10.1084/jem.164.4.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  18. Piatak M., Jr, Luk K. C., Williams B., Lifson J. D. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques. 1993 Jan;14(1):70–81. [PubMed] [Google Scholar]
  19. Spinas G. A., Keller U., Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest. 1992 Aug;90(2):533–536. doi: 10.1172/JCI115891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vitolo D., Zerbe T., Kanbour A., Dahl C., Herberman R. B., Whiteside T. L. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer. 1992 Jun 19;51(4):573–580. doi: 10.1002/ijc.2910510412. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES